Johnson & Johnson Family of Companies In Canada
Registration:
11
of
12
(2022-01-24
to
2024-05-21)
Policies or Program
- Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
- Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
- Health Canada Health Products & Food Regulatory Modernization
- Innovation Agenda led by Innovation, Science and Economic Development Canada, particularly with respect to the life sciences sector
- Patent Act as it relates to the regulation of intellectual property for therapeutic products
- Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)
- Patented Medicine Prices Review Board with respect to regulations of reporting obligations of patentees
- Patented Medicine Prices Review Board with respect to the regulation of pricing of patented drug products
- Policies or programs with respect to Federal Public Drug Benefit Programs
- Proposed and potential policies with respect to current or potential regulation of cross-border trade in pharmaceuticals, including the Export Control List
Regulation
- Food and Drug Regulations with respect to Data Protection under. C.08.004
- Medical Devices Regulations under the Food and Drugs Act, specifically with respect to the approval, regulation and life cycle management of medical devices
- Patent Act regulations as they relate to the regulation of intellectual property for therapeutic products and the Patented Medicines (Notice of Compliance) Regulations